Cyclin F, Neurodegeneration, and the Pathogenesis of ALS/FTD

Neuroscientist. 2024 Apr;30(2):214-228. doi: 10.1177/10738584221120182. Epub 2022 Sep 5.

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease and is characterized by the degeneration of upper and lower motor neurons of the brain and spinal cord. ALS is also linked clinically, genetically, and pathologically to a form of dementia known as frontotemporal dementia (FTD). Identifying gene mutations that cause ALS/FTD has provided valuable insight into the disease process. Several ALS/FTD-causing mutations occur within proteins with roles in protein clearance systems. This includes ALS/FTD mutations in CCNF, which encodes the protein cyclin F: a component of a multiprotein E3 ubiquitin ligase that mediates the ubiquitylation of substrates for their timely degradation. In this review, we provide an update on the link between ALS/FTD CCNF mutations and neurodegeneration.

Keywords: amyotrophic lateral sclerosis; cyclin F; familial mutations; frontotemporal dementia; neurodegeneration.

Publication types

  • Review

MeSH terms

  • Amyotrophic Lateral Sclerosis* / genetics
  • Amyotrophic Lateral Sclerosis* / metabolism
  • Cyclins / genetics
  • Cyclins / metabolism
  • Frontotemporal Dementia* / genetics
  • Frontotemporal Dementia* / metabolism
  • Humans
  • Motor Neurons / metabolism
  • Mutation

Substances

  • Cyclins